Morgan Stanley India Investment Fund Inc. (IIF)

Morgan Stanley India Investment Fund Inc. (IIF $27.30)
- $27.30 P/E (TTM): 0.02X Cap: $286M
- View IIF Profile
- View Questions on IIF

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Moderna Inc. (MRNA $27.61)
- $27.61 Cap: $10.67B
- View MRNA Profile
- View Questions on MRNA
Morgan Stanley India Investment Fund Inc. (IIF $27.30)
- $27.30 P/E (TTM): 0.02X Cap: $286M
- View IIF Profile
- View Questions on IIF

Q: I have a hefty loss on IIF held in a cash account, I am thinking of selling it to harvest the loss and use part of it to add to a small position of MRNA and/or some other health related stock that may benefit from work on COVID-19 vaccine that you may suggest.
Thank you.

Read Answer Asked by Carlos on March 31, 2020